About The Webinar

Biopharma and life sciences companies face unique challenges when valuing their research and development, clinical, commercial, and compassionate use products for cross-border transactions. These valuation decisions must comply with U.S. customs and tax laws, while complementing the company’s business and tax strategies. Every day, these companies enter into development and supply agreements, license technologies, sign royalty agreements, and source necessary materials to create innovative therapies. What often complicates these transactions is whether their value or cost must be added to the declared value of imported materials. This webinar provides an overview of basic U.S. customs law valuation principles and highlights specific areas for review relevant to the industry. 

Contact if you have issues registering. Please note we do not take American Express.

Key Topics

  • The World Customs Organization’s Customs Valuation Agreement
  • Basic concepts of customs valuation
  • Valuation tools and resources
  • Primary methods of appraisement
  • Meaning of “total payment” and “when sold for exportation to U.S.”
  • Understanding the five statutory additions to value
  • Treatment of related party transactions
  • Best practices for conducting reviews and declared value corrections


Andrea K. Jeglum


ANDREA K. JEGLUM is an associate for Sandler, Travis & Rosenberg, P.A., located in the Boston area. She concentrates her practice on customs compliance matters including tariff classification, country of origin, valuation, trade agreements, foreign-trade zones, and duty reduction programs. Prior to joining ST&R Ms. Jeglum served for more than 15 years leading global pharmaceutical and biotechnology companies through the complexities of global trade and related regulatory compliance matters.


Mark J. Segrist

Partner, Advisory Committee

MARK J. SEGRIST is a Partner, Advisory Committee with Sandler, Travis & Rosenberg, P.A., resident in the Portland, Maine office. His practice is focused primarily on import and export trade law and assisting clients in acquiring duty-saving benefits under the First Sale Rule and other customs declared value-related initiatives. With regard to imports, Mr. Segrist’s practice focuses primarily on providing strategic advice and counsel to a wide range of multinational clients on international trade and customs law matters. He also has extensive experience assisting clients in properly structuring multi-tiered transactions to maximize lawful duty savings under the First Sale Rule.



Cookie Consent

We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.